Novartis Ag (NVSEF) Debt Ratio (2009 - 2025)

Novartis Ag has disclosed Debt Ratio across 11 years of filings, most recently posting 0.26 for Q4 2025.

• Debt Ratio for Q4 2025 came in at 0.26, up 20.3% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.26 (up 20.3% YoY), and the FY2025 annual result was 0.26, up 20.3% from the prior year.
• Debt Ratio came in at 0.26 for Q4 2025 at Novartis Ag, down from 0.29 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.29 in Q2 2025 to a low of 0.19 in Q4 2023.
• The 5-year median for Debt Ratio is 0.24 (2022), against an average of 0.24.
• Across the five-year window, Debt Ratio slipped 14.43% in 2023 and grew 20.3% in 2025, its largest moves.
• Novartis Ag's Debt Ratio stood at 0.22 in 2021, then rose by 0.6% to 0.22 in 2022, then declined by 14.43% to 0.19 in 2023, then advanced by 12.87% to 0.22 in 2024, then grew by 20.3% to 0.26 in 2025.
• The last three Debt Ratio figures came in at 0.26 (Q4 2025), 0.29 (Q2 2025), and 0.22 (Q4 2024), per Business Quant data.